- Home
- RAPP vs LMB Comparison
RAPP vs LMB Comparison
Compare RAPP & LMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPP
- LMB
- Stock Information
- Founded
- RAPP 2022
- LMB 1901
- Country
- RAPP United States
- LMB United States
- Employees
- RAPP N/A
- LMB N/A
- Industry
- RAPP
- LMB Engineering & Construction
- Sector
- RAPP
- LMB Consumer Discretionary
- Exchange
- RAPP Nasdaq
- LMB Nasdaq
- Market Cap
- RAPP 1.2B
- LMB 1.2B
- IPO Year
- RAPP 2024
- LMB 2014
- Fundamental
- Price
- RAPP $25.93
- LMB $100.73
- Analyst Decision
- RAPP Strong Buy
- LMB Strong Buy
- Analyst Count
- RAPP 3
- LMB 3
- Target Price
- RAPP $35.33
- LMB $130.33
- AVG Volume (30 Days)
- RAPP 441.3K
- LMB 184.1K
- Earning Date
- RAPP 11-07-2025
- LMB 11-04-2025
- Dividend Yield
- RAPP N/A
- LMB N/A
- EPS Growth
- RAPP N/A
- LMB 35.95
- EPS
- RAPP N/A
- LMB 2.92
- Revenue
- RAPP N/A
- LMB $552,919,000.00
- Revenue This Year
- RAPP N/A
- LMB $28.57
- Revenue Next Year
- RAPP N/A
- LMB $14.48
- P/E Ratio
- RAPP N/A
- LMB $34.43
- Revenue Growth
- RAPP N/A
- LMB 8.06
- 52 Week Low
- RAPP $6.43
- LMB $63.02
- 52 Week High
- RAPP $42.27
- LMB $154.05
- Technical
- Relative Strength Index (RSI)
- RAPP 52.13
- LMB 54.70
- Support Level
- RAPP $24.85
- LMB $90.26
- Resistance Level
- RAPP $27.17
- LMB $96.62
- Average True Range (ATR)
- RAPP 1.46
- LMB 4.69
- MACD
- RAPP -0.37
- LMB 1.46
- Stochastic Oscillator
- RAPP 49.28
- LMB 87.62
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
About LMB Limbach Holdings Inc.
Limbach Holdings Inc is a commercial specialty contractor in the fields of heating, ventilation, air conditioning, plumbing, electrical, and building controls for the design and construction of new and renovated buildings, maintenance services, energy retrofits, and equipment upgrades. It operates in two segments namely General Contractor Relationships (GCR) and Owner Direct Relationships (ODR). The company generates maximum revenue from the ODR segment.